Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
暂无分享,去创建一个
D. Yekutieli | D. Nass | A. Kanner | S. Harnof | Y. Mardor | D. Last | D. Guez | D. Daniels | S. Salomon | D. Blumenthal | G. Tsarfaty | C. Hoffmann | F. Bokstein | L. Zach | A. Talianski | Z. Cohen | S. Zamir